MIT’s new AI screens millions of molecules at supercomputer speed

The race to accelerate drug discovery has found a powerful ally.

Boltz-2, a next-generation biomolecular foundation model developed by MIT’s Jameel Clinic and CSAIL in collaboration with Utah-based biotech startup Recursion, the AI model…